Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 11 points (0.1%) at 16,218 as of Tuesday, Feb. 25, 2014, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,600 issues advancing vs. 1,298 declining with 186 unchanged. The Health Services industry currently sits down 0.4% versus the S&P 500, which is up 0.2%. A company within the industry that increased today was Agilent Technologies ( A), up 1.2%. On the negative front, top decliners within the industry include Tenet Healthcare ( THC), down 8.0%, Fresenius Medical Care AG & Co. KGaA ( FMS), down 5.4%, Community Health Systems ( CYH), down 3.9%, ResMed ( RMD), down 2.9% and DaVita HealthCare Partners ( DVA), down 1.5%. TheStreet would like to highlight 3 stocks pushing the industry higher today: 3. Catamaran ( CTRX) is one of the companies pushing the Health Services industry higher today. As of noon trading, Catamaran is up $1.08 (2.1%) to $52.49 on average volume. Thus far, 785,109 shares of Catamaran exchanged hands as compared to its average daily volume of 1.4 million shares. The stock has ranged in price between $51.35-$52.73 after having opened the day at $51.72 as compared to the previous trading day's close of $51.41. Catamaran Corporation provides pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefits management industry in North America. The company operates in two segments: PBM and HCIT. Catamaran has a market cap of $10.5 billion and is part of the health care sector. Shares are up 7.7% year-to-date as of the close of trading on Monday. Currently there are 12 analysts who rate Catamaran a buy, no analysts rate it a sell, and 5 rate it a hold. TheStreet Ratings rates Catamaran as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, compelling growth in net income, good cash flow from operations and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Catamaran Ratings Report now. 3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.